Genes modulated by both PML/RARα and PLZF/RARα
. | GenBank accession no. . | . | PML/RARα . | . | PLZF/RARα . | . | ||
---|---|---|---|---|---|---|---|---|
Gene . | . | Description . | Fold change* . | P† . | Fold change* . | P† . | ||
Down-regulated gene | ||||||||
ELA2 | M20203 | Neutrophil elastase | 4713.3 | <.0001 | 3053.6 | <.0001 | ||
PRTN3 | X55668 | Proteinase 3 (serine proteinase, neutrophil, Wegener granulomatosis autoantigen) | 1217.5 | .0002 | 1217.5 | .0002 | ||
PAI2 | M31551 | Plasminogen activator inhibitor, type II | 1109.8 | <.0001 | 1109.8 | <.0001 | ||
CEBPA | U34070 | CCAAT/enhancer binding protein (C/EBP), alpha | 85.1 | .02 | 85.1 | .02 | ||
GAL | M77140 | Galanin | 230.5 | .01 | 314.7 | .009 | ||
PPP5 | X89416 | Protein phosphatase 5, catalytic subunit | 373.4 | .01 | 252.8 | .07 | ||
NFKBIE | U91616 | Nuclear factor of kappa light polypeptide gene enhancer in B-cell inhibitor, epsilon | 59.5 | .008 | 47.3 | .01 | ||
PECAM1 | L34657 | Platelet-endothelial cell adhesion molecule (CD31 antigen) | 182.5 | .03 | 146.9 | .03 | ||
MEF2 | HG4668-HT5083 | Transcription factor Mef2, alt Splice 2 | 129.5 | .05 | 179.7 | .04 | ||
RAB31 | U59877 | Ras-associated protein RAB31; Low Mr GTP-binding protein of the Rab subfamily | 162.0 | .001 | 162.0 | .003 | ||
NMB | X76534 | Glycoprotein NMB; GPNMB; neuromedin B | 31.7 | .0003 | 221.7 | .0003 | ||
NFIL6 | HG3494-HT3688 | Nuclear factor, NF-IL6 (C/EBP beta) | 6.2 | .04 | 10.8 | .03 | ||
IFI30 | J03909 | Interferon-gamma-inducible protein 30; GILT | 97.2 | .06 | 21.0 | .06 | ||
ELA2 | M27783 | Elastase 2, neutrophil | 1816.2 | .001 | 19.9 | .001 | ||
MNDA | M81750 | Myeloid cell nuclear differentiation antigen | 6.1 | .03 | 14.8 | .02 | ||
CGII | U61836 | Cyclin G1 interacting protein | 92.9 | .007 | 8.6 | .007 | ||
IL-8 | M28130 | Human interleukin-8 gene | 3.0 | .02 | 8.7 | .006 | ||
LYZ | M21119 | Lysozyme | 13.9 | .001 | 17.5 | .001 | ||
SPI1 | X52056 | Spleen focus-forming virus (SFFV) proviral integration oncogene spi1 | 8.7 | .03 | 143.3 | .03 | ||
MCAM | M29277 | Melanoma adhesion molecule | 8.2 | .5 | 9.5 | .8 | ||
CYBB | X04011 | Cytochrome b-245, beta polypeptide (chronic granulomatous disease); p91-phox | 98.0 | .008 | 55.6 | <.0001 | ||
LSP1 | M33552 | Lymphocyte-specific protein 1 (LSP1) | 260.1 | .02 | 261.9 | .02 | ||
EPR1 | L32866 | Human effector cell protease receptor-1; EPR-1 | 117.1 | .02 | 11.8 | .03 | ||
PRG1 | X17042 | Proteoglycan 1, secretory granule | 35.2 | <.0001 | 16.2 | <.0001 | ||
APP | Y00264 | Amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease) | 40.6 | .006 | 91.5 | .005 | ||
IL-8 | Y00787 | Interleukin-8 | 14.5 | .0005 | 274.7 | .0001 | ||
GLVR1 | L20859 | Solute carrier family 20, member 1 (SLC20A1) | 4.7 | .01 | 5.1 | .01 | ||
MCP1 | HG4069-HT4339 | Monocyte chemotactic protein 1 | 6.4 | .002 | 8.7 | .002 | ||
ASAH | U70063 | N-acylsphingosine amidohydrolase | 153.6 | .05 | 159.7 | .06 | ||
COL4A2 | X05610 | Collagen type IV, alpha-2; COL4A2 | 453.2 | .0002 | 6.8 | .0002 | ||
RAB27A | U57094 | RAB27A, member RAS oncogene family | 3.1 | .1 | 8.0 | .07 | ||
S100P | X65614 | S100 calcium-binding protein P | 8.8 | .009 | 4.5 | .02 | ||
TUBA1 | HG2259-HT2348 | Tubulin Alpha 1, isoform 44 | 497.3 | .005 | 549.3 | .003 | ||
RNASE3 | X55990 | Ribonuclease, RNase A family, 3 (eosinophil cationic protein) | 3.5 | .005 | 4.1 | .004 | ||
BTG1 | X61123 | B-cell translocation gene 1, antiproliferative | 3.0 | .1 | 67.1 | .02 | ||
ERBAL2 | X12794 | v-erbA—related ear-2 gene; nuclear receptor subfamily 2, group F, member 6 | 3.4 | .003 | 3.2 | .008 | ||
P63 | X69910 | p63 transmembrane protein | 3.2 | .008 | 4.3 | .006 | ||
CTSD | M63138 | Cathepsin D | 3.8 | .02 | 3.3 | .03 | ||
ZYX | X95735 | Zyxin | 4.1 | .02 | 3.4 | .02 | ||
CORO1A | X89109 | Coronin 1A | 3.0 | .006 | 3.6 | .005 | ||
CES1 | L07765 | Carboxylesterase 1 (monocyte/macrophage serine esterase 1) | 5.0 | .03 | 7.6 | .03 | ||
QSCN6 | L42379 | Quiescin Q6 | 2.4 | .0007 | 4.4 | .0003 | ||
CHS1 | U67615 | Chediak-Higashi syndrome 1; lysosomal trafficking regulator (LYST) | 3.1 | .03 | 5.6 | .02 | ||
NEU1 | X78687 | Neuraminidase 1 | 3.9 | .03 | 88.5 | .04 | ||
CTSB | HG417-HT417 | Cathepsin B | 3.9 | .005 | 5.9 | .009 | ||
junB | U20734 | Oncogene jun-B | 2.6 | .1 | 2.7 | .09 | ||
VAT1 | U18009 | Vesicle amine transport protein 1 | 5.1 | .001 | 2.6 | .0007 | ||
FKBP5 | U42031 | FK506-binding protein 5 | 5.3 | .01 | 25.0 | .01 | ||
PTPNS1 | U06681 | Protein tyrosine phosphatase, non-receptor type substrate 1 | 92.9 | .007 | 8.6 | .007 | ||
SRPK1 | U09564 | Protein kinase, SR splicing factor specific, 1 | 4.3 | .0002 | 3.7 | .0002 | ||
ENT1 | U81375 | Equilibrative nucleoside transporter 1; solute carrier family 29, member 1 (SLC29A1) | 2.7 | .04 | 2.5 | .04 | ||
NK4 | M59807 | Natural killer cell transcript 4 | 2.7 | .02 | 2.9 | .02 | ||
TPRC | X99720 | TFE3-PRCC fusion transcript; renal cell carcinoma, papillary, 1 (PRCC1) | 3.5 | .1 | 3.6 | .1 | ||
SRF | J03161 | Serum response factor (c-fos serum response element-binding transcription factor) | 3.2 | .002 | 3.0 | .003 | ||
GLUL | X59834 | Glutamate-ammonia ligase (glutamine synthase) | 2.9 | .03 | 2.7 | .07 | ||
PRKCA | X52479 | Protein kinase C, alpha | 3.2 | .02 | 2.6 | .02 | ||
GPI | K03515 | Glucose-6-phosphate isomerase | 3.0 | .004 | 2.4 | .006 | ||
Up-regulated gene | ||||||||
MPO | M19507 | Myeloperoxidase | 1237.1 | < .0001 | 1794.3 | .0003 | ||
PKCI-1 | U51004 | Putative protein kinase C inhibitor | 4.3 | .005 | 4.5 | .001 | ||
TMSB10 | S54005 | Thymosin, beta-10 | 3.9 | .004 | 3.7 | .0008 | ||
STIP1 | M86752 | Stress-induced phosphoprotein, STIP1 | 2.4 | .0006 | 2.4 | .009 | ||
PSME2 | D45248 | Proteasome (prosome, macropain) activator subunit 2 (PA28 beta) | 2.9 | .2 | 3.3 | .07 | ||
MPO | M19508 | Myeloperoxidase precursor A | 2.2 | .03 | 3.9 | .006 | ||
PSMB9 | X66401 | Proteasome (prosome, macropain) subunit, beta type, 9 | 3.5 | .0006 | 3.3 | .0002 | ||
SELPLG | U25956 | Selectin P ligand | 2.7 | .02 | 2.8 | .01 | ||
SOX4 | X70683 | SRY (sex-determining region Y)-box 4 | 7.7 | < .0001 | 8.6 | .004 | ||
AHR | L19872 | Aryl hydrocarbon receptor | 6.0 | .06 | 5.0 | .05 | ||
SUCLG1 | Z68204 | Succinate-CoA ligase, GDP-forming, alpha subunit | 3.0 | .0002 | 2.7 | .0006 | ||
UFD2 | D50916 | Homolog of yeast (S cerevisiae) ufd2 | 3.0 | .2 | 4.4 | .03 | ||
ANX1 | X05908 | Annexin I (lipocortin I) | 44.5 | .03 | 43.9 | .06 | ||
GZMA | M18737 | Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | 44.4 | .03 | 139.6 | .004 | ||
MEF2C | L08895 | MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C) | 27.7 | .001 | 36.9 | .04 |
. | GenBank accession no. . | . | PML/RARα . | . | PLZF/RARα . | . | ||
---|---|---|---|---|---|---|---|---|
Gene . | . | Description . | Fold change* . | P† . | Fold change* . | P† . | ||
Down-regulated gene | ||||||||
ELA2 | M20203 | Neutrophil elastase | 4713.3 | <.0001 | 3053.6 | <.0001 | ||
PRTN3 | X55668 | Proteinase 3 (serine proteinase, neutrophil, Wegener granulomatosis autoantigen) | 1217.5 | .0002 | 1217.5 | .0002 | ||
PAI2 | M31551 | Plasminogen activator inhibitor, type II | 1109.8 | <.0001 | 1109.8 | <.0001 | ||
CEBPA | U34070 | CCAAT/enhancer binding protein (C/EBP), alpha | 85.1 | .02 | 85.1 | .02 | ||
GAL | M77140 | Galanin | 230.5 | .01 | 314.7 | .009 | ||
PPP5 | X89416 | Protein phosphatase 5, catalytic subunit | 373.4 | .01 | 252.8 | .07 | ||
NFKBIE | U91616 | Nuclear factor of kappa light polypeptide gene enhancer in B-cell inhibitor, epsilon | 59.5 | .008 | 47.3 | .01 | ||
PECAM1 | L34657 | Platelet-endothelial cell adhesion molecule (CD31 antigen) | 182.5 | .03 | 146.9 | .03 | ||
MEF2 | HG4668-HT5083 | Transcription factor Mef2, alt Splice 2 | 129.5 | .05 | 179.7 | .04 | ||
RAB31 | U59877 | Ras-associated protein RAB31; Low Mr GTP-binding protein of the Rab subfamily | 162.0 | .001 | 162.0 | .003 | ||
NMB | X76534 | Glycoprotein NMB; GPNMB; neuromedin B | 31.7 | .0003 | 221.7 | .0003 | ||
NFIL6 | HG3494-HT3688 | Nuclear factor, NF-IL6 (C/EBP beta) | 6.2 | .04 | 10.8 | .03 | ||
IFI30 | J03909 | Interferon-gamma-inducible protein 30; GILT | 97.2 | .06 | 21.0 | .06 | ||
ELA2 | M27783 | Elastase 2, neutrophil | 1816.2 | .001 | 19.9 | .001 | ||
MNDA | M81750 | Myeloid cell nuclear differentiation antigen | 6.1 | .03 | 14.8 | .02 | ||
CGII | U61836 | Cyclin G1 interacting protein | 92.9 | .007 | 8.6 | .007 | ||
IL-8 | M28130 | Human interleukin-8 gene | 3.0 | .02 | 8.7 | .006 | ||
LYZ | M21119 | Lysozyme | 13.9 | .001 | 17.5 | .001 | ||
SPI1 | X52056 | Spleen focus-forming virus (SFFV) proviral integration oncogene spi1 | 8.7 | .03 | 143.3 | .03 | ||
MCAM | M29277 | Melanoma adhesion molecule | 8.2 | .5 | 9.5 | .8 | ||
CYBB | X04011 | Cytochrome b-245, beta polypeptide (chronic granulomatous disease); p91-phox | 98.0 | .008 | 55.6 | <.0001 | ||
LSP1 | M33552 | Lymphocyte-specific protein 1 (LSP1) | 260.1 | .02 | 261.9 | .02 | ||
EPR1 | L32866 | Human effector cell protease receptor-1; EPR-1 | 117.1 | .02 | 11.8 | .03 | ||
PRG1 | X17042 | Proteoglycan 1, secretory granule | 35.2 | <.0001 | 16.2 | <.0001 | ||
APP | Y00264 | Amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease) | 40.6 | .006 | 91.5 | .005 | ||
IL-8 | Y00787 | Interleukin-8 | 14.5 | .0005 | 274.7 | .0001 | ||
GLVR1 | L20859 | Solute carrier family 20, member 1 (SLC20A1) | 4.7 | .01 | 5.1 | .01 | ||
MCP1 | HG4069-HT4339 | Monocyte chemotactic protein 1 | 6.4 | .002 | 8.7 | .002 | ||
ASAH | U70063 | N-acylsphingosine amidohydrolase | 153.6 | .05 | 159.7 | .06 | ||
COL4A2 | X05610 | Collagen type IV, alpha-2; COL4A2 | 453.2 | .0002 | 6.8 | .0002 | ||
RAB27A | U57094 | RAB27A, member RAS oncogene family | 3.1 | .1 | 8.0 | .07 | ||
S100P | X65614 | S100 calcium-binding protein P | 8.8 | .009 | 4.5 | .02 | ||
TUBA1 | HG2259-HT2348 | Tubulin Alpha 1, isoform 44 | 497.3 | .005 | 549.3 | .003 | ||
RNASE3 | X55990 | Ribonuclease, RNase A family, 3 (eosinophil cationic protein) | 3.5 | .005 | 4.1 | .004 | ||
BTG1 | X61123 | B-cell translocation gene 1, antiproliferative | 3.0 | .1 | 67.1 | .02 | ||
ERBAL2 | X12794 | v-erbA—related ear-2 gene; nuclear receptor subfamily 2, group F, member 6 | 3.4 | .003 | 3.2 | .008 | ||
P63 | X69910 | p63 transmembrane protein | 3.2 | .008 | 4.3 | .006 | ||
CTSD | M63138 | Cathepsin D | 3.8 | .02 | 3.3 | .03 | ||
ZYX | X95735 | Zyxin | 4.1 | .02 | 3.4 | .02 | ||
CORO1A | X89109 | Coronin 1A | 3.0 | .006 | 3.6 | .005 | ||
CES1 | L07765 | Carboxylesterase 1 (monocyte/macrophage serine esterase 1) | 5.0 | .03 | 7.6 | .03 | ||
QSCN6 | L42379 | Quiescin Q6 | 2.4 | .0007 | 4.4 | .0003 | ||
CHS1 | U67615 | Chediak-Higashi syndrome 1; lysosomal trafficking regulator (LYST) | 3.1 | .03 | 5.6 | .02 | ||
NEU1 | X78687 | Neuraminidase 1 | 3.9 | .03 | 88.5 | .04 | ||
CTSB | HG417-HT417 | Cathepsin B | 3.9 | .005 | 5.9 | .009 | ||
junB | U20734 | Oncogene jun-B | 2.6 | .1 | 2.7 | .09 | ||
VAT1 | U18009 | Vesicle amine transport protein 1 | 5.1 | .001 | 2.6 | .0007 | ||
FKBP5 | U42031 | FK506-binding protein 5 | 5.3 | .01 | 25.0 | .01 | ||
PTPNS1 | U06681 | Protein tyrosine phosphatase, non-receptor type substrate 1 | 92.9 | .007 | 8.6 | .007 | ||
SRPK1 | U09564 | Protein kinase, SR splicing factor specific, 1 | 4.3 | .0002 | 3.7 | .0002 | ||
ENT1 | U81375 | Equilibrative nucleoside transporter 1; solute carrier family 29, member 1 (SLC29A1) | 2.7 | .04 | 2.5 | .04 | ||
NK4 | M59807 | Natural killer cell transcript 4 | 2.7 | .02 | 2.9 | .02 | ||
TPRC | X99720 | TFE3-PRCC fusion transcript; renal cell carcinoma, papillary, 1 (PRCC1) | 3.5 | .1 | 3.6 | .1 | ||
SRF | J03161 | Serum response factor (c-fos serum response element-binding transcription factor) | 3.2 | .002 | 3.0 | .003 | ||
GLUL | X59834 | Glutamate-ammonia ligase (glutamine synthase) | 2.9 | .03 | 2.7 | .07 | ||
PRKCA | X52479 | Protein kinase C, alpha | 3.2 | .02 | 2.6 | .02 | ||
GPI | K03515 | Glucose-6-phosphate isomerase | 3.0 | .004 | 2.4 | .006 | ||
Up-regulated gene | ||||||||
MPO | M19507 | Myeloperoxidase | 1237.1 | < .0001 | 1794.3 | .0003 | ||
PKCI-1 | U51004 | Putative protein kinase C inhibitor | 4.3 | .005 | 4.5 | .001 | ||
TMSB10 | S54005 | Thymosin, beta-10 | 3.9 | .004 | 3.7 | .0008 | ||
STIP1 | M86752 | Stress-induced phosphoprotein, STIP1 | 2.4 | .0006 | 2.4 | .009 | ||
PSME2 | D45248 | Proteasome (prosome, macropain) activator subunit 2 (PA28 beta) | 2.9 | .2 | 3.3 | .07 | ||
MPO | M19508 | Myeloperoxidase precursor A | 2.2 | .03 | 3.9 | .006 | ||
PSMB9 | X66401 | Proteasome (prosome, macropain) subunit, beta type, 9 | 3.5 | .0006 | 3.3 | .0002 | ||
SELPLG | U25956 | Selectin P ligand | 2.7 | .02 | 2.8 | .01 | ||
SOX4 | X70683 | SRY (sex-determining region Y)-box 4 | 7.7 | < .0001 | 8.6 | .004 | ||
AHR | L19872 | Aryl hydrocarbon receptor | 6.0 | .06 | 5.0 | .05 | ||
SUCLG1 | Z68204 | Succinate-CoA ligase, GDP-forming, alpha subunit | 3.0 | .0002 | 2.7 | .0006 | ||
UFD2 | D50916 | Homolog of yeast (S cerevisiae) ufd2 | 3.0 | .2 | 4.4 | .03 | ||
ANX1 | X05908 | Annexin I (lipocortin I) | 44.5 | .03 | 43.9 | .06 | ||
GZMA | M18737 | Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | 44.4 | .03 | 139.6 | .004 | ||
MEF2C | L08895 | MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C) | 27.7 | .001 | 36.9 | .04 |